FWAFX
Price
$34.09
Change
-$1.25 (-3.54%)
Updated
Dec 18 closing price
RNPEX
Price
$64.62
Change
-$2.05 (-3.07%)
Updated
Dec 18 closing price
Ad is loading...

FWAFX vs RNPEX

Header iconFWAFX vs RNPEX Comparison
Open Charts FWAFX vs RNPEXBanner chart's image
Fidelity Advisor Worldwide A
Price$34.09
Change-$1.25 (-3.54%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R4
Price$64.62
Change-$2.05 (-3.07%)
VolumeN/A
CapitalizationN/A
FWAFX vs RNPEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FWAFX vs. RNPEX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FWAFX is a StrongBuy and RNPEX is a Buy.

FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 149B vs. FWAFX (3.31B). RNPEX pays higher dividends than FWAFX: RNPEX (0.83) vs FWAFX (0.56). FWAFX was incepted earlier than RNPEX: FWAFX (16 years) vs RNPEX (23 years). FWAFX is a more actively managed with annual turnover of: 114.00 vs. RNPEX (17.00). FWAFX has a lower initial minimum investment than RNPEX: FWAFX (0) vs RNPEX (250). RNPEX annual gain was more profitable for investors over the last year : 23.10 vs. FWAFX (17.52). RNPEX return over 5 years is better than : 40.88 vs. FWAFX (29.87).
FWAFXRNPEXFWAFX / RNPEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years23 years-
Gain YTD16.21721.48375%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.31B149B2%
Annual Yield % from dividends0.560.8368%
Returns for 1 year17.5223.1076%
Returns for 3 years5.257.2273%
Returns for 5 years29.8740.8873%
Returns for 10 years61.0276.0580%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHD105.80-0.02
-0.02%
Church & Dwight Co
BZH30.01-0.61
-1.99%
Beazer Homes USA
ESEA34.12-0.76
-2.18%
Euroseas Ltd
BHVN39.12-2.32
-5.60%
Biohaven Ltd
NXTC0.90-0.11
-10.82%
NextCure